Several companies have GLP-1/glucose-dependent insulinotropic polypeptide (GIP) dual agonists in phase 1 studies, including SCO-094 (Scohia Pharma), VK2735 (Viking Therapeutics) and CT-388 (Carmot Therapeutics)
Meal timing affects comfort and nausea tolerance, not the medication's ability to suppress appetite or improve blood sugar control
Every step of the process, from the first injection to reaching the 12 mg maintenance phase, is designed with your health in mind
It can be a great option, but many people hesitate when needles are involved, so it's not necessarily right for everyone
L-carnitine also has antioxidant properties that contribute to the maintenance of cell and tissue health [2]
A large protein, BPC was claimed in a 1994 US patent (#5,288,708) to have been isolated from both human and animal gastric juice and to exert a wide-range of protective effects in organ injury models